Recent Updates
Recently added Catalysts
SLDB

Solid Biosciences Present Upcoming Scientific And Patient

Thursday, June 23, 2022 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Solid Biosciences Present Upcoming Scientific And Patient
Price reaction · baseline $8.2935 (2022-06-22 close) · hit after-hours · clean, no other SLDB news in the window
day 0 close
+8.5%
day 1
+5.4%
day 3 · peak
+14.6%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma

Full Press Release Details

Solid Biosciences Present Upcoming Scientific And Patient.
ShareAdd on Google
Tags: SLDB Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jun 23, 2022

Biotech snapshot

Cash runway
$378M liquidity · $18M/mo burn
~21 mo
Low dilution risk
Lead asset
carmustinePhase 3
Lymphoma →

Catalyst track record

+116%
best trade around SLDB's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for SLDB.

See every catalyst's timing & PoA →